ELUTIA INC. - CLASS A COMMON STOCK

Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021

26 Jul 2021 15:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix

07 Jun 2021 07:00:02 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

28 Apr 2021 15:05:01 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit

26 Apr 2021 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

20 Apr 2021 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

01 Mar 2021 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Cowen 41st Annual Health Care Conference

18 Feb 2021 15:05:01 By Nasdaq GlobeNewswire

Aziyo Biologics Announces First Patient Enrolled in HEAL Study

17 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021

15 Feb 2021 11:00:00 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Product Design Completion for its Next Generation CanGaroo® Envelope for Implantable Electronic Devices

11 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibiotic Solution

28 Jan 2021 15:05:01 By Nasdaq GlobeNewswire